Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC
Status:
Recruiting
Trial end date:
2026-10-30
Target enrollment:
Participant gender:
Summary
This study aims to observe and explore the efficacy and safety of Penpulimab combined with
chemotherapy for neoadjuvant and adjuvant therapy in patients with resectable head and neck
squamous cell carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University